Kainic acid and neurotransmitter interactions in the basal ganglia.
D000818:Animals; D001369:Axons / Q000378:metabolism; D001479:Basal Ganglia / Q000187:drug effects*; D003712:Dendrites / Q000378:metabolism; D004298:Dopamine / Q000502:physiology; D004347:Drug Interactions; D006801:Humans; D007608:Kainic Acid / Q000494:pharmacology*; D009411:Nerve Endings / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D013134:Spiperone / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism
D018377:Neurotransmitter Agents; D011759:Pyrrolidines; D013134:Spiperone; D011813:Quinuclidinyl Benzilate; D007608:Kainic Acid; D004298:Dopamine